Publications

Follow us on
C.J. Malanga

 
 
 


Bilbao A, Robinson JE, Heilig M, Malanga CJ, Spanagel R, Sommer W, and Thorsell A: A pharmacogenetic determinant of mu-opioid receptor antagonist effects on alcohol reward and consumption: Evidence from humanized mice. Biological Psychiatry, accepted for publication August 2014

White KL, Robinson JE, Zhu H, DiBerto JF, Polepally PR, Zjawiony JK, Nichols D, Malanga CJ, and Roth BL: The G protein-biased k-opioid receptor agonist RB-64 is analgesic with a unique spectrum of activities in vivo. Journal of Pharmacology and Experimental Therapeutics 352(1): 98-109, 2014 [Epub 2014 Oct 15] PubMed

Fish EW, DiBerto JF, Krouse MC, Robinson JE, and Malanga CJ: Different contributions of dopamine D1 and D2 receptor activity to alcohol potentiation of brain stimulation reward in C57BL/6J and DBA/2J mice. Journal of Pharmacology and Experimental Therapeutics 350(2): 322-29, 2014 [Epub 2014 Jun 10] PubMed

Fish EW, Whitman BJ, DiBerto JF, Robinson JE, Morrow AL, and Malanga CJ: Effects of the neuroactive steroid allopregnanolone on intracranial self-stimulation in C57BL/6J mice. Psychopharmacology 231(17): 3415-23, 2014 [Epub 2014 May 9] PubMed

Fish EW, Agoglia AE, Krouse MC, Muller RG, Robinson JE, and Malanga CJ: Levetiracetam results in increased and decreased alcohol drinking with different access procedures in C57BL/6J mice. Behavioural Pharmacology 25(1): 61-70, 2013 [Epub 2013 Dec 9] PubMed

Fish EW, Krouse MC, Stringfield SJ, DiBerto JF, Robinson JE, and Malanga CJ: Changes in sensitivity of reward and motor behavior to dopaminergic, glutamatergic, and cholinergic drugs in a mouse model of Fragile X syndrome. PLoS ONE 8(10): e77896, 2013 [Epub 2013 Oct 18] PubMed

Robinson JE, Chen M, Stamatakis AM, Krouse MC, Howard EC, Faccidomo S, Hodge CW, Fish EW, and Malanga CJ: Levetiracetam has opposite effects on alcohol- and cocaine-related behaviors in C57BL/6J mice. Neuropsychopharmacology 38(7): 1322-33, 2013 [Epub 2013 Jan 25] PubMed

Riday TT, Dankoski E, Krouse MC, Fish EW, Walsh PL, Han JE, Hodge CW, Wightman RM, Philpot BD, and Malanga CJ: Pathway-specific dopaminergic deficits in a mouse model of Angelman syndrome. Journal of Clinical Investigation 122(12): 4544-54, 2012 [Epub 2012 Nov 12] PubMed

Robinson JE, Agoglia AE, Fish EW, Krouse MC, and Malanga CJ: Mephedrone (4-methylmethcathinone) and intracranial self-stimulation in C57BL/6J mice: comparison to cocaine. Behavioral Brain Research 234: 76-81, 2012 [Epub 2012 Jun 21] PubMed

Riday TT, Kosofsky BE, and Malanga CJ: The rewarding and locomotor-sensitizing effects of repeated cocaine administration are distinct and separable in mice. Neuropharmacology 62(4): 1858-66, 2012 [Epub 2011 Dec 16] PubMed

Riday TT, Fish EW, Robinson JE, Jarrett TM, McGuigan MM, and Malanga CJ: Orexin-1 receptor antagonism does not reduce the rewarding potency of cocaine in mice. Brain Research 1431: 53-61, 2012 [Epub 2011 Nov 7] PubMed

Fish EW, Robinson JE, Krouse MC, Hodge CW, Reed C, Phillips TJ, and Malanga CJ: Intracranial self-stimulation in FAST and SLOW mice: Effects of alcohol and cocaine. Psychopharmacology 220(4): 719-30, 2012 [Epub 2011 Oct 7] PubMed

Robinson JE, Fish EW, Krouse MC, Thorsell A, Heilig M, and Malanga CJ: Potentiation of brain stimulation reward by morphine: Effects of neurokinin-1 receptor antagonism. Psychopharmacology 220(1): 215-24, 2012 [Epub 2011 Sep 10] PubMed

Sanger TD, Chen D, Fehlings DL, Hallett M, Lang AE, Mink JW, Singer H, Alter K, Ben-Pazi H, Butler E, Chen R, Collins A, Dayanidhi S, Forssberg H, Fowler E, Gilbert DL, Gorman SI, Gormley Jr ME, Jinnah H, Kornblau B, Krosschell K, Lehman RK, MacKinnon C, Malanga CJ, Mesterman R, Michaels MB, Pearson TS, Rose J, Russman B, Sternad D, Swoboda K, and Valero-Cuevas F: Definition and classification of hyperkinetic movements in childhood. Movement Disorders 25(11): 1538-49, 2010 [Epub 2010 Jun 29] PubMed

Timmermann L, Pauls KAM, Wieland K, Jech R, Kurlemann G, Sharma N, Gill SS, Haenggeli CA, Hayflick SJ, Hogarth P, Leenders KL, Limousin P, Malanga CJ, Moro E, Ostrem JL, Revilla FJ, Santens P, Tisch S, Valldeoriola F, Vesper J, Volkmann J, Woitalla D, Wojtecki L, and Peker S: Dystonia in Neurodegeneration with Brain Iron Accumulation: outcome of bilateral pallidal stimulation. Brain 133(Pt 3): 701-712, 2010 [Epub 2010 Mar 5] PubMed

Fish EW, Riday TT, McGuigan MM, Faccidomo S, Hodge CW, and Malanga CJ: Alcohol, cocaine and brain stimulation-reward in C57Bl6/J and DBA2/J Mice. Alcohol Clin Exp Res 34(1): 81-89, 2010 [Epub 2009 Oct 23] PubMed

Malanga CJ: Still no time for complacency: Developmental effects of prenatal methamphetamine exposure. Neurology 72(24): 2062-2063, 2009 [Epub 2009 Apr 29] PubMed

Malanga CJ, Ren JQ, Guerriero R, and Kosofsky BE: Augmentation of dopamine release by cocaine in the nucleus accumbens of adult mice following prenatal exposure to cocaine. Developmental Neuroscience 31(1-2): 76 – 89, 2009 [Epub 2009 Apr 17] PubMed

Malanga CJ, Riday TT, Carlezon WA, and Kosofsky BE: Prenatal exposure to cocaine increases the rewarding potency of cocaine and selective dopaminergic agonists in adult mice. Biological Psychiatry 63: 214-221, 2008 [Epub 2007 Jun 13] PubMed

Malanga CJ, Pejchal M, and Kosofsky BE: Prenatal exposure to cocaine alters the development of conditioned place-preference to cocaine in adult mice. Pharmacology Biochemistry and Behavior 87(4): 462-471, 2007 [Epub 2007 Jun 21] PubMed

Ren JQ, Malanga CJ, and Kosofsky BE: Neuropathological consequences of prenatal cocaine exposure in the mouse. Int J Developmental Neuroscience 22(5/6): 309-320, 2004. PubMed

Malanga CJ and Kosofsky BE: Does drug abuse beget drug abuse? Behavioral analysis of addiction liability in animal models of prenatal drug exposure. Developmental Brain Res 147: 47-57, 2003. PubMed